Atezolizumab

Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck

Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck

2 monthes ago   |   Xconomy

A Roche immunotherapy has won an additional FDA approval as a first-line treatment for non-small lung cancer, bolstering the product's competitive stance versus one from Merck...
Read more ...

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

5 monthes ago   |   Xconomy   |   2 articles

The treatment landscape for lung cancer has shifted significantly over the past few years , and more changes could be on the way. At the World Conference on Lung Cancer in...
Read more ...

Merck Data Are Another Step for Immunotherapy in Breast Cancer

Merck Data Are Another Step for Immunotherapy in Breast Cancer

6 monthes ago   |   Xconomy

Merck this morning announced that a combination of its drug pembrolizumab and chemotherapy succeeded in a Phase 3 study in breast cancer, a potentially notable advance for...
Read more ...

Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects?

Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects?

8 monthes ago   |   Xconomy

Drugs that rev up a patient's immune system have changed how we treat cancers of the skin, lung, and more, offering people whose tumors have spread a chance to live longer than...
Read more ...

AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results

AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results

10 monthes ago   |   Xconomy

[ Editor's note: Alex Lash co-authored this report ] The American Association for Cancer Research's annual meeting is wrapping up in Atlanta today. The conference typically...
Read more ...

Bio Roundup: Golumbeski's Legacy, CRISPR Moratorium, Rebate Week & More

Bio Roundup: Golumbeski's Legacy, CRISPR Moratorium, Rebate Week & More

11 monthes ago   |   Xconomy

While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb's proposal to buy Celgene for $74 billion , it wasn't that long ago that another...
Read more ...

Merck Scooping Up Cancer Drug Developer Immune Design for $300M

Merck Scooping Up Cancer Drug Developer Immune Design for $300M

One year ago   |   Xconomy   |   2 articles

Four months after Immune Design halted a late-stage study for its lead cancer vaccine and saw its stock price cut nearly in half, the immunotherapy company is now in line to...
Read more ...

Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo

Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo

One year ago   |   Xconomy

An Eli Lilly drug on the market for a rare form of cancer is now in limbo, after it failed a trial needed to retain the FDA approval the treatment, known as olaratumab , won...
Read more ...

Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

One year ago   |   Xconomy

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. The patent holder, the University...
Read more ...

Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up

Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up

One year ago   |   Xconomy

Nivolumab recently became the first immunotherapy ever approved for people with small cell lung cancer , a particularly aggressive form of the deadly disease. But the lead...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...